CHICAGO — An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new study.
The benefit from the study’s exercise program was about as large as what researchers might expect from a new drug, experts said, and came from a randomized controlled trial, the gold standard of medical research. Such studies are common for pharmaceuticals, but are difficult to conduct and unusual for exercise programs.
